Barriers and Facilitators to the Use of Genomic-Based Targeted Lung Cancer Therapies in the VA: Qualitative Findings.
Journal: Federal Practitioner : For The Health Care Professionals Of The VA, DoD, And PHS
Published:
Abstract
Reflexive testing, standardization of the mutation test ordering procedure and results reporting, and elimination of the preauthorization requirements could facilitate the utilization of targeted therapies.
Authors
Jennifer Arney, Ashley Helm, Ursula Braun, G Chen, Teresa Hayes
Relevant Conditions